drugset / Trial / NCT03996447

Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

NCT03996447

Phase 3 Completed 260 enrolled Guerbet
RandomizedCrossoverQuadruple-blindDiagnostic

Summary

This trial aimed to evaluate the Efficacy and Safety of gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Timeline

Start
2019-06-03
Primary completion
2020-09-11
Completion
2020-09-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadobutrol Diagnostic / imaging agent Intravenous
Subject Gadopiclenol Diagnostic / imaging agent Intravenous

Indications

No indication recorded.